Past, Present, and Future of Blood Biomarkers for the Diagnosis of Acute Myocardial Infarction—Promises and Challenges

Despite important advancements in acute myocardial infarction (AMI) management, it continues to represent a leading cause of mortality worldwide. Fast and reliable AMI diagnosis can significantly reduce mortality in this high-risk population. Diagnosis of AMI has relied on biomarker evaluation for m...

Descripción completa

Detalles Bibliográficos
Autores principales: Tilea, Ioan, Varga, Andreea, Serban, Razvan Constantin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156776/
https://www.ncbi.nlm.nih.gov/pubmed/34063483
http://dx.doi.org/10.3390/diagnostics11050881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156776/
https://www.ncbi.nlm.nih.gov/pubmed/34063483
http://dx.doi.org/10.3390/diagnostics11050881

Ejemplares similares